167 related articles for article (PubMed ID: 22222041)
1. Inhibitors incorporating zinc-binding groups target the GlcNAc-PI de-N-acetylase in Trypanosoma brucei, the causative agent of African sleeping sickness.
Abdelwahab NZ; Crossman AT; Sullivan L; Ferguson MA; Urbaniak MD
Chem Biol Drug Des; 2012 Mar; 79(3):270-8. PubMed ID: 22222041
[TBL] [Abstract][Full Text] [Related]
2. Fragment screening reveals salicylic hydroxamic acid as an inhibitor of Trypanosoma brucei GPI GlcNAc-PI de-N-acetylase.
Urbaniak MD; Capes AS; Crossman A; O'Neill S; Thompson S; Gilbert IH; Ferguson MA
Carbohydr Res; 2014 Mar; 387(100):54-8. PubMed ID: 24589444
[TBL] [Abstract][Full Text] [Related]
3. Cloning of Trypanosoma brucei and Leishmania major genes encoding the GlcNAc-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol biosynthesis that is essential to the African sleeping sickness parasite.
Chang T; Milne KG; Güther ML; Smith TK; Ferguson MA
J Biol Chem; 2002 Dec; 277(51):50176-82. PubMed ID: 12364327
[TBL] [Abstract][Full Text] [Related]
4. The N-acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase of glycosylphosphatidylinositol biosynthesis is a zinc metalloenzyme.
Urbaniak MD; Crossman A; Chang T; Smith TK; van Aalten DM; Ferguson MA
J Biol Chem; 2005 Jun; 280(24):22831-8. PubMed ID: 15817455
[TBL] [Abstract][Full Text] [Related]
5. Probing enzymes late in the trypanosomal glycosylphosphatidylinositol biosynthetic pathway with synthetic glycosylphosphatidylinositol analogues.
Urbaniak MD; Yashunsky DV; Crossman A; Nikolaev AV; Ferguson MA
ACS Chem Biol; 2008 Oct; 3(10):625-34. PubMed ID: 18928250
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of potential metal-binding group compounds to examine the zinc dependency of the GPI de-N-acetylase metalloenzyme in Trypanosoma brucei.
Abdelwahab NZ; Urbaniak MD; Ferguson MA; Crossman AT
Carbohydr Res; 2011 May; 346(6):708-14. PubMed ID: 21377660
[TBL] [Abstract][Full Text] [Related]
7. Designing sleeping sickness control.
Kinoshita T
ACS Chem Biol; 2008 Oct; 3(10):601-3. PubMed ID: 18928247
[TBL] [Abstract][Full Text] [Related]
8. In silico drug re-purposing against African sleeping sickness using GlcNAc-PI de-N-acetylase as an experimental target.
Rashmi M; Swati D
Comput Biol Chem; 2015 Dec; 59 Pt A():87-94. PubMed ID: 26476127
[TBL] [Abstract][Full Text] [Related]
9. Specificity of GlcNAc-PI de-N-acetylase of GPI biosynthesis and synthesis of parasite-specific suicide substrate inhibitors.
Smith TK; Crossman A; Borissow CN; Paterson MJ; Dix A; Brimacombe JS; Ferguson MA
EMBO J; 2001 Jul; 20(13):3322-32. PubMed ID: 11432820
[TBL] [Abstract][Full Text] [Related]
10. Probing the substrate specificity of Trypanosoma brucei GlcNAc-PI de-N-acetylase with synthetic substrate analogues.
Capes AS; Crossman A; Urbaniak MD; Gilbert SH; Ferguson MA; Gilbert IH
Org Biomol Chem; 2014 Mar; 12(12):1919-34. PubMed ID: 24519084
[TBL] [Abstract][Full Text] [Related]
11. Differences between the trypanosomal and human GlcNAc-PI de-N-acetylases of glycosylphosphatidylinositol membrane anchor biosynthesis.
Sharma DK; Smith TK; Weller CT; Crossman A; Brimacombe JS; Ferguson MA
Glycobiology; 1999 Apr; 9(4):415-22. PubMed ID: 10089216
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided discovery of Trypanosoma brucei RNA-editing terminal uridylyl transferase 2 inhibitors.
Demir O; Labaied M; Merritt C; Stuart K; Amaro RE
Chem Biol Drug Des; 2014 Aug; 84(2):131-9. PubMed ID: 24903413
[TBL] [Abstract][Full Text] [Related]
13. Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
Bayliss T; Robinson DA; Smith VC; Brand S; McElroy SP; Torrie LS; Mpamhanga C; Norval S; Stojanovski L; Brenk R; Frearson JA; Read KD; Gilbert IH; Wyatt PG
J Med Chem; 2017 Dec; 60(23):9790-9806. PubMed ID: 29125744
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibitors of the glycosylphosphatidylinositol biosynthetic pathway of Trypanosoma brucei.
Smith TK; Sharma DK; Crossman A; Brimacombe JS; Ferguson MA
EMBO J; 1999 Nov; 18(21):5922-30. PubMed ID: 10545104
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of Trypanosoma brucei trypanothione synthetase inhibitors.
Spinks D; Torrie LS; Thompson S; Harrison JR; Frearson JA; Read KD; Fairlamb AH; Wyatt PG; Gilbert IH
ChemMedChem; 2012 Jan; 7(1):95-106. PubMed ID: 22162199
[TBL] [Abstract][Full Text] [Related]
16. Partial purification and characterization of the N-acetylglucosaminyl-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol anchor biosynthesis in African trypanosomes.
Milne KG; Field RA; Masterson WJ; Cottaz S; Brimacombe JS; Ferguson MA
J Biol Chem; 1994 Jun; 269(23):16403-8. PubMed ID: 8206949
[TBL] [Abstract][Full Text] [Related]
17. Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors: toward the development of novel therapies for African sleeping sickness.
Durrant JD; Urbaniak MD; Ferguson MA; McCammon JA
J Med Chem; 2010 Jul; 53(13):5025-32. PubMed ID: 20527952
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma brucei CTP synthetase: a target for the treatment of African sleeping sickness.
Hofer A; Steverding D; Chabes A; Brun R; Thelander L
Proc Natl Acad Sci U S A; 2001 May; 98(11):6412-6. PubMed ID: 11353848
[TBL] [Abstract][Full Text] [Related]
19. Trypanosome glycosylphosphatidylinositol biosynthesis.
Hong Y; Kinoshita T
Korean J Parasitol; 2009 Sep; 47(3):197-204. PubMed ID: 19724691
[TBL] [Abstract][Full Text] [Related]
20. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
